Literature DB >> 31345017

Telmisartan alleviates inflammatory response and myocardial apoptosis in diabetic cardiomyopathy rats through TGF-β1/Smad signaling pathway.

Wenzhen Wu1, Wen Liu1, Degui Kong2.   

Abstract

Entities:  

Year:  2019        PMID： 31345017     DOI： 10.23736/S0026-4806.19.06201-3

Source DB:  PubMed          Journal:  Minerva Med        ISSN： 0026-4806            Impact factor:   4.806


× No keyword cloud information.
  3 in total

1.  MiR-208b/miR-21 Promotes the Progression of Cardiac Fibrosis Through the Activation of the TGF-β1/Smad-3 Signaling Pathway: An in vitro and in vivo Study.

Authors:  Yifan Zhang; Bo Yuan; Yue Xu; Na Zhou; Ruiqi Zhang; Lan Lu; Zhanbin Feng
Journal:  Front Cardiovasc Med       Date:  2022-07-05

Review 2.  Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.

Authors:  Meng-Ling Peng; Yu Fu; Chu-Wen Wu; Ying Zhang; Hang Ren; Shan-Shan Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-15       Impact factor: 6.055

3.  Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1).

Authors:  Ling Chen; Jiajia Xu; Meiyu Deng; Yanling Liang; Jinfu Ma; Linghui Zhang; Yijie Wang; Jinping Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.